Brain changes in depression.

Area of Science:

• Neuroscience
• Psychiatry
• Cell Biology

Background:

• Major depressive disorder (MDD) is linked to stress, impacting neurofunctional, neuroendocrine, neurobiological, and neuroimmune systems.
• Brain neuroplasticity, initially considered secondary, is now recognized as central to MDD remission.
• Neurons exhibit adaptive potential, highlighting neuroplasticity's role in neural defense against stress.

Purpose of the Study:

• To review the role of antidepressant treatment in modulating brain neuroplasticity for MDD.
• To explore neuroplasticity as a fundamental mechanism in neural defense against stress.
• To elucidate the mechanisms of neuroplasticity relevant to MDD pathophysiology and treatment.

Main Methods:

• Review of experimental animal studies on stress and neuroplasticity.
• Analysis of human studies in mood disorder subjects examining neuroplasticity.
• Examination of structural and functional neuroplasticity mechanisms.

Main Results:

• Neuroplasticity is the fundamental mechanism of neural defense against stress in both animal and human studies.
• Structural neuroplasticity (e.g., neurogenesis, dendritic reconstruction) and synaptic neuroplasticity are key dimensions.
• These neuroplasticity mechanisms explain MDD pathophysiology and stress convergence.

Conclusions:

• Neuroplasticity is central to MDD remission and represents a primary target for novel antidepressant treatments.
• Understanding the interplay between stress, MDD, and neuroplasticity is vital for therapeutic advancements.
• Targeting neuroplasticity offers a promising avenue for developing effective antidepressant strategies.